OndaCast
Back to Wall Street Breakfast
Lilly weight loss drug succeeds in sleep apnea trial
Episode April 17, 2024

Lilly weight loss drug succeeds in sleep apnea trial

From Wall Street Breakfast • Seeking Alpha
Zepbound sees positive outcomes in Phase 3 clinical trials for sleep disorder. (0:16) Walmart teams up with Jessica Simpson. (3:25) Cathie Wood's flagship ARRK ETF falls below key technical level. (3:42)

Show Notes
Wedbush says these housing stocks can benefit from rising interest rates

Episode transcripts seekingalpha.com/wsb
Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.

You May Also Like

NPR News Now

NPR News Now

NPR

Noticentro

Noticentro

Audio Centro

ABC News Top Stories

ABC News Top Stories

ABC Australia

Kan Hourly News כאן רשת ב חדשות השעה

Kan Hourly News כאן רשת ב חדשות השעה

Mr. Mp3

Bulwark Takes

Bulwark Takes

The Bulwark

America Out Loud News

America Out Loud News

America Out Loud News

The Epstein Chronicles

The Epstein Chronicles

Bobby Capucci

The True Crime Tapes

The True Crime Tapes

Bobby Capucci

Bloomberg News Now

Bloomberg News Now

Bloomberg

ABC News Update

ABC News Update

ABC News

NPR News Now

NPR News Now

NPR

Noticentro

Noticentro

Audio Centro

ABC News Top Stories

ABC News Top Stories

ABC Australia

Kan Hourly News כאן רשת ב חדשות השעה

Kan Hourly News כאן רשת ב חדשות השעה

Mr. Mp3

Bulwark Takes

Bulwark Takes

The Bulwark

America Out Loud News

America Out Loud News

America Out Loud News

The Epstein Chronicles

The Epstein Chronicles

Bobby Capucci

The True Crime Tapes

The True Crime Tapes

Bobby Capucci

Bloomberg News Now

Bloomberg News Now

Bloomberg

ABC News Update

ABC News Update

ABC News

Community discussion

Join the conversation
OndaCast © 2026 OndaCast. All rights reserved.
HelpContactTermsPrivacyCopyrightDMCAAboutRadio GuideEmbed Player
Waves Search Community Library